Kannada Prabha: “Cancer surgery: MIMS steps towards a milestone”

On 2 December 2025 the Kannada daily Kannada Prabha carried on the front page of its Mandya edition the report “ಕ್ಯಾನ್ಸರ್ ಶಸ್ತ್ರಚಿಕಿತ್ಸೆ: ಮೈಲಿಗಲ್ಲಿನತ್ತ ಮಿಮ್ಸ್ ಹೆಜ್ಜೆ” (“Cancer surgery: MIMS steps towards a milestone”), on the two-year research programme of Mandya Institute of Medical Sciences (MIMS) and ManMed Dynamics to identify, in real time, cancer tissue that can remain after a tumour is removed.

How the study works, as the report describes it

In the first phase, excised breast and colorectal tumour specimens are examined ex vivo in a light-tight box in the MIMS pathology laboratory. Indocyanine green (ICG) fluorescence, excited by near-infrared light at about 785 nm, is captured through emission filters by a monochrome scientific camera and processed on an edge-computing module, where a learning-based AI model highlights regions that may hold residual cancer at the surgical margin.

Each AI result is compared with histopathology, the gold standard; data are de-identified and kept under version control with audit trails. The report stresses that the AI supports, and never replaces, the clinical decision, and that the system is being designed to be affordable for government and district hospitals.

The team, as named in the report

• Dr P. Narasimhaswamy, Director, MIMS: institutional leadership, regulatory coordination and coordination across departments.
• Dr N. Lingaraju, neurosurgeon, chief investigator: patient selection, preservation of surgical specimens and comparison of the results with cancer care.
• Dr Y. Muralidhara Bhat, pathologist, co-investigator: comparison of every result with histopathology (H&E).
• Ing. Vishwas Gowda P N, co-founder of ManMed Dynamics, technical lead investigator: the engineering, from concept, optics and imaging hardware to edge computing and the AI model. The report notes that he is from Panakanahalli in Mandya taluk and was then studying for a master’s degree in mechatronics, specialising in surgical robotics, at the University of Duisburg-Essen in Germany.

The study is at the research stage and has not reported results. More about the work on the OncoVision page.

Source: Kannada Prabha, Mandya edition, 2 December 2025, page 1 (clipping above; e-paper linked above). Summary and translation from Kannada by ManMed Dynamics.